NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Hikal (HIKAL) Technical (Analysis) Reports Hikal ["Technical Analysis"] Reports -NSE Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Hikal (HIKAL)

Technical Analysis Report for NSE stock HIKAL Hikal. Dated: 13 Mar 2026 Updated Daily. Stock trades under Pharmaceuticals in NSE stock exchange

If you are looking for Tomorrow's Movement Predictions for NSE stock HIKAL Hikal then click here. or read Experts views on Hikal or Forecast & share price targets of Hikal

Hikal Opened at 178.00 and Closed at: 172.41, which is -4.55% of previous session's close. It moved within a range of 172.05 and 179.35
The session was a Bearish session with an average volume of 287648, which is 9.17% of previous session's volumes.

• The stock has fallen, and its short term trend is also negative and in a downtrend.
• The stock has fallen, and its mid term trend is also negative and in a downtrend.
• The stock has fallen, and its long term trend is also negative and in a downtrend.

A Dead cross was found 7 days back on short term averages

Support for tomorrow is 168.58 and resistance for tomorrow is 175.88
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 169.86, 167.3 resistance for tomorrow's hourly charts is 177.16, 181.9

10 Day SMA for Hikal (HIKAL) is 182.81 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Hikal (HIKAL) is 193.62 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Hikal (HIKAL) is 199.72 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 218 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Hikal is 261.99 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Hikal is at 193.62 and 200 DMA is at 261.99, while 50 DMA and 100 DMA are at 199.72 and 218 respectively

Hikal (HIKAL) moving average of 20 SMA is at 193.62 and 20 EMA is at 188.67

Hikal (HIKAL) moving average of 50 SMA is at 199.72 and 50 EMA is at 200.49

Hikal (HIKAL) moving average of 100 SMA is at 218 and 100 EMA is at 219.33

Hikal (HIKAL) moving average of 200 SMA is at 261.99 and 200 EMA is at 253.07

Vivimed Labs has performed better than Hikal in short term. You could have earned much better returns by investing in Vivimed Labs, about 12.1% more returns!

Divi S has performed better than Hikal in short term. You could have earned much better returns by investing in Divi S, about 17.67% more returns!

Alembic Pharmaceuticals has performed better than Hikal in short term. You could have earned much better returns by investing in Alembic Pharmaceuticals, about 7.31% more returns!

Aurobindo Pharma has performed better than Hikal in short term. You could have earned much better returns by investing in Aurobindo Pharma, about 32.42% more returns!

Bal Pharma has performed better than Hikal in short term. You could have earned much better returns by investing in Bal Pharma, about 11.31% more returns!

Hikal has performed better than Brooks Laboratories in short term. Holding Hikal could be a better choice for now!

Caplin Point has performed better than Hikal in short term. You could have earned much better returns by investing in Caplin Point, about 15.26% more returns!

Glaxosmithkline Pharmaceuticals has performed better than Hikal in short term. You could have earned much better returns by investing in Glaxosmithkline Pharmaceuticals, about 12.69% more returns!

Hester Biosciences has performed better than Hikal in short term. You could have earned much better returns by investing in Hester Biosciences, about 8.77% more returns!

Ipca Laboratories has performed better than Hikal in short term. You could have earned much better returns by investing in Ipca Laboratories, about 24.36% more returns!

Kopran has performed better than Hikal in short term. You could have earned much better returns by investing in Kopran, about 5.9% more returns!

Krebs Biochem has performed better than Hikal in short term. You could have earned much better returns by investing in Krebs Biochem, about 8.45% more returns!

Lincoln Pharma has performed better than Hikal in short term. You could have earned much better returns by investing in Lincoln Pharma, about 11.45% more returns!

Lupin has performed better than Hikal in short term. You could have earned much better returns by investing in Lupin, about 24.51% more returns!

Marksans Pharma has performed better than Hikal in short term. You could have earned much better returns by investing in Marksans Pharma, about 11.14% more returns!

Neuland Laboratories has performed better than Hikal in short term. You could have earned much better returns by investing in Neuland Laboratories, about 12.33% more returns!

Pfizer has performed better than Hikal in short term. You could have earned much better returns by investing in Pfizer, about 11.02% more returns!

Suven Life has performed better than Hikal in short term. You could have earned much better returns by investing in Suven Life, about 10.07% more returns!

Themis Medicare has performed better than Hikal in short term. You could have earned much better returns by investing in Themis Medicare, about 5.15% more returns!

Hikal Technical analysis of indicators

Price action analysis of Hikal (HIKAL) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Hikal stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.

MACD generated a SELL signal for Hikal in short term and the sell signal is strong.

Hikal Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Hikal in short term and SELL signal is strong!

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Hikal is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 182.09 and Hikal HIKAL stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Hikal HIKAL stock. Volume based technical analysis of Hikal HIKAL stock is negative.

Hikal Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NSE stock HIKAL Hikal These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And HIKAL Experts View which covers a lot of information including buying and selling signals

HIKAL future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Hikal or View Candle Stick Charts here

Share on: WhatsApp Facebook Tweet